Furthermore, ECAS total scores did not correlate with the number of SMN2 copies in treatment-naive patients with SMA type 2 (ρ = − 0.557, p = 0.222) and type 3 (ρ = 0.188, p = 0.513). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.